FREMANEZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 12:22:15 GMT 2023` Edited by `admin` on `Sat Dec 16 12:22:15 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG2A
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	PF8K38CG54
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

FREMANEZUMAB

Official Name

English

FREMANEZUMAB [JAN]

Common Name

English

fremanezumab [INN]

Common Name

English

RN-307

Code

English

LBR-101

Code

English

IMMUNOGLOBULIN G2, ANTI-(HUMAN .ALPHA.-CALCITONIN GENE-RELATED PEPTIDE/.BETA.-CALCITONIN GENE-RELATED PEPTIDE) (HUMAN-MUS MUSCULUS MONOCLONAL TEV-48125 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL TEV-48125 LIGHT CHAIN, DIMER

Systematic Name

English

TEV-48125

Code

English

FREMANEZUMAB [MI]

Common Name

English

IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS CALCITONIN GENE-RELATED PEPTIDE 1 (CGRP-I))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.2 HEAVY CHAIN (1-448) (HUMANIZED VH (HOMO SAPIENS IGHV3-7*01 (86%) (IGHD)-IGHJ5*01) (8.10.13) (1-122) -HOMO SAPIENS IGHG2*01 (CH2(A

Systematic Name

English

RN307

Code

English

LBR101

Code

English

TEV48125

Code

English

PF-04472429

Code

English

FREMANEZUMAB [USAN]

Common Name

English

PF04472429

Code

English

Fremanezumab [WHO-DD]

Common Name

English

Code System Code Type Description

DAILYMED

PF8K38CG54

Created by admin on Sat Dec 16 12:22:15 GMT 2023 , Edited by admin on Sat Dec 16 12:22:15 GMT 2023

PRIMARY

CAS

1655501-53-3

Created by admin on Sat Dec 16 12:22:15 GMT 2023 , Edited by admin on Sat Dec 16 12:22:15 GMT 2023

PRIMARY

NCI_THESAURUS

C174842

Created by admin on Sat Dec 16 12:22:15 GMT 2023 , Edited by admin on Sat Dec 16 12:22:15 GMT 2023

PRIMARY

INN

10299

Created by admin on Sat Dec 16 12:22:15 GMT 2023 , Edited by admin on Sat Dec 16 12:22:15 GMT 2023

PRIMARY

DRUG BANK

DB14041

Created by admin on Sat Dec 16 12:22:15 GMT 2023 , Edited by admin on Sat Dec 16 12:22:15 GMT 2023

PRIMARY

DRUG CENTRAL

5315

Created by admin on Sat Dec 16 12:22:15 GMT 2023 , Edited by admin on Sat Dec 16 12:22:15 GMT 2023

PRIMARY

USAN

FG-93

Created by admin on Sat Dec 16 12:22:15 GMT 2023 , Edited by admin on Sat Dec 16 12:22:15 GMT 2023

PRIMARY

RXCUI

2056691

Created by admin on Sat Dec 16 12:22:15 GMT 2023 , Edited by admin on Sat Dec 16 12:22:15 GMT 2023

PRIMARY

FDA UNII

PF8K38CG54

Created by admin on Sat Dec 16 12:22:15 GMT 2023 , Edited by admin on Sat Dec 16 12:22:15 GMT 2023

PRIMARY

SMS_ID

100000172849

Created by admin on Sat Dec 16 12:22:15 GMT 2023 , Edited by admin on Sat Dec 16 12:22:15 GMT 2023

PRIMARY

RXCUI

2056690

Created by admin on Sat Dec 16 12:22:15 GMT 2023 , Edited by admin on Sat Dec 16 12:22:15 GMT 2023

ALTERNATIVE

WIKIPEDIA

Fremanezumab

Created by admin on Sat Dec 16 12:22:15 GMT 2023 , Edited by admin on Sat Dec 16 12:22:15 GMT 2023

PRIMARY

MERCK INDEX

m12104

Created by admin on Sat Dec 16 12:22:15 GMT 2023 , Edited by admin on Sat Dec 16 12:22:15 GMT 2023

PRIMARY

LACTMED

Fremanezumab

Created by admin on Sat Dec 16 12:22:15 GMT 2023 , Edited by admin on Sat Dec 16 12:22:15 GMT 2023

PRIMARY

From	To
1_22	1_98
1_136	3_214
1_149	1_205
1_224	2_224
1_225	2_225
1_228	2_228
1_231	2_231
1_262	1_322
1_368	1_426
2_22	2_98
2_136	4_214
2_149	2_205
2_262	2_322
2_368	2_426
3_23	3_88
3_134	3_194
4_23	4_88
4_134	4_194

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_298
N	2_298

Related Record Type Details


					JHB2QIZ69Z

CALCITONIN GENE-RELATED PEPTIDE

TARGET -> INHIBITOR

Interaction Type:

BINDING

FREMANEZUMAB-VFRM

INNOVATOR->PARENT

FREMANEZUMAB-VFRM

SUB_CONCEPT->SUBSTANCE

Related Record Type Details


					PF8K38CG54

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL